CBASP
Cross-source consensus on CBASP from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Preparation
Evidence quality
Highlighted claims
- CBASP is the only psychotherapy developed specifically for persistent depressive disorder. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- CBASP uses interpersonal techniques to help patients recognise behavioural consequences and acquire more effective interpersonal skills. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- No randomised controlled trial had previously tested CBASP systematically in institutional inpatient settings. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- The CBASP acute phase includes an introduction stage, a main treatment stage, and relapse prevention. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- CBASP assumes impaired interpersonal functioning in chronic early-onset depression often results from child maltreatment. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial